Molecular-biological problems of drug design and mechanism of drug action: Mechanisms of rutin pharmacological action (review)

Pharmaceutical Chemistry Journal

Volumn 48, Issue 2, 2014, Pages 73-76

  Koval'skii, I V ^a   Krasnyuk, I I ^a   Krasnyuk Jr , I I ^a   Nikulina, O I ^a   Belyatskaya, A V ^a   Kharitonov, Yu Ya ^a   Feldman, N B ^a   Lutsenko, S V ^a  

^a I M SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Mechanisms of action; Properties; Rutin; Rutin aglycone

Indexed keywords

AGLYCONE; CYCLOSPORIN; DIGOXIN; DOXORUBICIN; FREE RADICAL; PACLITAXEL; RUTOSIDE; SIMVASTATIN; TAMOXIFEN; VERAPAMIL;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; DRUG ABSORPTION; DRUG BINDING; DRUG DESIGN; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG MECHANISM; DRUG METABOLISM; HUMAN; NONHUMAN; REVIEW;

EID: 84904314618     PISSN: 0091150X     EISSN: 15739031     Source Type: Journal    
DOI: 10.1007/s11094-014-1050-6     Document Type: Review

References (53)

1. J. A. Ross and C. M. Kasum, Annu. Rev. Nutr., 22, 19-34 (2002).
2. V. Cody, Prog. Clin. Biol. Res., 280-282 (1988).
3. J. Cao, Y. Zhang, W. Chen, and X. Zhao, Br. J. Nutr., 103, 249-255 (2010).
4. S. H. Hakkien, S. O. Karenlampi, I. M. Heinonen, et al., J. Agric. Food Chem., 47, 2274-2279 (1999).
5. S. Scholz and G. Williamson, Int. J. Vitam. Nutr. Res., 77, 224-235 (2007).
6. G. Williamson and C. Manach, Am. J. Clin. Nutr., 81, 243-255 (2005).
7. M. D. Mashkovskii, Drugs [in Russian], RIA Novaya Volna, Moscow (2007), pp. 629-631.
8. V. Crespy, C. Morand, C. Besson, et al., J. Agric. Food Chem., 50, 618-621 (2002).
9. S. Scholz and G. Williamson, Int. J. Vitam. Nutr. Res., 77, 224-235 (2007).
10. T. Walle, A. M. Browning, L. L. Steed, et al., J. Nutr., 135, 48-52 (2005).
11. X. Chen, O. Q. P. Yin, Z. Zuo, and M. S. S. Chow, Pharm. Res., 22, 892-901 (2005).
12. B. A. Graf, C. Ameho, G. G. Dolnikowski, et al., J. Nutr., 136, 39-44 (2006).
13. V. C. de Boer, A. A. Dihal, H. van der Woude, et al., J. Nutr., 135, 1718-1725 (2005).
14. K. Azuma, K. Ippoushi, H. Ito, et al., Biosci. Biotechnol. Biochem., 67, 2548-2555 (2003).
15. M. Mamani-Matsuda, T. Kauss, A. Al-Kharrat, et al., Biochem. Pharmacol., 72,1304-1310 (2006).
16. D. A. Valerio, S. R. Georgetti, D. A. Magro, et al., J. Nat. Prod., 72, 1975-1979 (2009).
17. S. R. McAnulty, L. S. McAnulty, D. C. Nieman, et al., Appl. Physiol., Nutr., Metab., 33, 254-262 (2008).
18. M. Inam, M. Altinisik, and M. D. Bilgin, Cell Biochem. Funct., 20, 291-296 (2002).
19. I. Huk, V. Brovkovych, J. Nanobash Vili, et al., Br. J. Surg., 85, 1080-1085 (1998).
20. S. Das, A. K. Mandal, A. Ghosh, et al., Curr. Aging Sci., 1, 169-174 (2008).
21. A. Kahraman, N. Erkasap, and M. Serteser, J. Nephrol., 16, 219-224 (2003).
22. A. M. Seufi, S. S. Ibrahim, and T. K. Elmaghraby, J. Exp. Clin. Cancer Res., 20, 80 (2009).
23. C. V. DeWhalley, J. F. Rankin, S. M. Rankin, et al., Biochem. Pharmacol., 39, 1743-1749 (1990).
24. J. F. Su, C. J. Guo, J. Y. Wei, et al., Biomed. Environ. Sci., 16, 1-8 (2003).
25. S. Egert, C. Boesch-Saadatmandi, S. Wolffram, et al., J. Nutr., 140, 278-284 (2010).
26. S. Juzwiak, J.Wojcincki, K. Mokrzicki, et al., Pharmacol. Rep., 57, 604-609 (2005).
27. L. Zhao, J. Wu, Y. Wang, et al., J. Agric. Food Chem., 59, 1104-1108 (2011).
28. Y. Yamamoto and E. Oue, Biosci. Biotechnol. Biochem., 70, 933-939 (2006).
29. F. Perez-Vizcaino, J. Duarte, R. Jimenez, et al., Pharmacol. Rep., 61, 67-75 (2009).
30. K. T. Calamia, Experiment Med. Biol., 44, 545-547 (2003).
31. W. W. Buss, D. E. Kopp, and E. Middleton, Allergy Clin. Immunol., 73, 801-809 (1984).
32. H. P. Kim, I. Mani, and V. A. Ziboh, Prostaglandins Leukotrienes Essent. Fatty Acids, 58, 17-24 (1998).
33. M. G. Ortega, A. C. Saragusti, J. L. Cabrera, and G. A. Chiabrando, Arch. Biochem. Biophys., 498, 105-110 (2010).
34. T. Yokoo and M. Kitamura, Am. J. Physiol., 273, 206-212 (1997).
35. J. Levy, I. Teuerstein, M. Marbach, et al., Biochem. Biophys. Res. Commun., 123, 1227-1233 (1984).
36. J. A. Boutin, Int. J. Biochem., 26, 1203-1226 (1994).
37. M. Joskova, S. Franova, and V. Sadlonova, Bratisl. Lek. Listy, 112, 9-12 (2011).
38. H. Moon, H. H. Choi, J. Y. Lee, et al., Arch. Pharm. Res., 31, 771-778 (2008).
39. A. P. Rogerio, C. L. Dora, E. L. Andrade, et al., Pharmacol. Res., 61, 288-297 (2010).
40. C. C. Chuang, K. Martinez, G. Xie, et al., Am. J. Clin. Nutr., 92, 1511-1521 (2010).
41. R. Vidya Priadarsini, R. Senthil Murugan, S. Maitreyi, et al., Eur. J. Pharmacol., 649, 84-91 (2010).
42. R. L. Sighal, Y. A. Yeh, N. Prajda, et al., Biochem. Biophys. Res. Commun., 208, 425-431 (1995).
43. M. Yoshida, M. Yamamoto, and T. Nikaido, Cancer Res., 52, 6676-6681 (1992).
44. M. Yoshida, T. Sakai, N. Hosokawa, et al., FEBS Lett., 260, 10-13 (1990).
45. G. Sliutz, J. Karlseder, C. Tempfer, et al., Br. J. Cancer, 74, 172-177 (1996).
46. R. Aalinkeel, B. Bundukumar, J. L. Reynolds, et al., Prostate, 68, 1773-1789 (2008).
47. S. H. Kim, G. S. Yeo, Y. S. Lim, et al., Exp. Mol. Med., 30, 87-92 (1998).
48. S. L. Hsiu, Y. C. Hou, Y. H. Wang, et al., Life Sci., 72, 227-235 (2002).
49. Y. Chen, P. Xiao, D. S. Ou-Yang, et al., Clin. Exp. Pharmacol. Physiol., 36,828-833 (2009).
50. R. Cermak, S. Wein, S. Wolffram, and P. Langguch, Eur. J. Pharm. Sci., 38, 519-524 (2009).
51. J. S. Choi, Y. J. Piao, and K. W. Kang, Arch. Pharmacal Res., 34, 607-613 (2011).
52. J. S. Choi and H. K. Han, J. Pharm. Pharmacol. 56, 1537-1542 (2004).
53. Y. H. Wang, P. D. Chao, S. L. Hsiu, et al., Clin. Exp. Pharmacol. Physiol., 74, 1191-1197 (2004)